miRNA Sequencing and Assay Market Report 2022: Rise in Adoption of RNA Sequencing Protocols in Biotechnology Research Drives Growth - ResearchAndMarkets.com
The global miRNA sequencing and assay market size is expected to reach USD 823.5 million by 2030. The market is expected to register a CAGR of 13.25% from 2022 to 2030 owing to the growing application areas of miRNA sequencing in the healthcare sector. For instance, various research studies stated that miRNAs can be efficiently used as biomarkers in the prognosis and diagnosis of cancer (cervical, ovarian, and breast), sepsis, cardiovascular diseases, and nervous system conditions. Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders. For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.
Prominent players such as PerkinElmer Inc.; Illumina, Inc.; and Qiagen offer innovative sequencing products for several clinical applications. Furthermore, these companies have entered into several strategic initiatives with research institutes to expand the sequencing application in research studies. For instance, in January 2022, BIORCHESTRA, a South Korean biopharmaceutical company, entered into a partnership agreement with SK Biopharmaceuticals to accelerate research and development into novel therapeutic compounds that target miRNAs.
Key market players are involved in the development of new tools, instruments, and kits with high specificity and reproducibility, which is fueling the market growth. For instance, in October 2019, TriLink BioTechnologies introduced two primer sets for its CleanTag kit. Thermo Fisher Scientific's sequencer platform can prepare small RNA libraries using these new Ion Torrent Convert barcode primer sets. Such launches are expected to boost market growth.
miRNA Sequencing And Assay Market Report Highlights
By product & service, product dominated the market in 2021. This is due to the presence of several key companies that offer a broad range of consumables, kits, and instruments for specific applications
By technology, sequencing by synthesis led the market in 2021. This is due to its fast turnaround time, high sensitivity, and high throughput. Moreover, it plays a key role in the mutation detection of tumor tissue, which helps to develop personalized therapies
By workflow, sequencing captured the largest share in 2021 as it is the most important step in the workflow. It has become a key research tool in biological research and several disease diagnoses
By application, cancer dominated the market in 2021. Several ongoing research in cancer using miRNA as a biomarker to study the prognosis and diagnosis of cancer to develop new therapies is contributing to the segment growth
By end-use, research and academic institutes led the market in 2021 with a revenue share of over 50.0%. The growth is attributed to the increased R&D studies conducted by academic institutes using miRNA sequencing techniques
Asia Pacific is projected to witness the highest growth during the forecast period. This is due to the growing healthcare infrastructure, significant targeted population, and high unmet clinical needs
Market Dynamics
Market Drivers
Advantages of miRNA Sequencing
miRNAs as Critical Regulators of Health and Disease
Rise in Prevalence of Cancer and Autoimmune Disorders
Rise in Adoption of RNA Sequencing Protocols in Biotechnology Research
Market Restraints
Limitations Associated with Bioinformatic Analysis of MicroRNA Sequencing Data
Market Opportunities
Efforts Taken to Optimize Mirna-Seq Data Processing
Market Challenge Analysis
Challenges Associated with The Validation and Prediction of miRNA Targetome
Ryan, a leading global tax services and software provider, is pleased to announce that Chitranjan Sharma has been appointed as Chief Data Officer (CDO). Sharma brings more than a decade of extensive experience in building technology and data...
GLOW Production, a leading cinematic development company in Malaysia, today announced it is opening its business to North American studios that have struggled to find sufficient international resources that can meet expedited pipelines and deliver...
CNFinance Holdings Limited ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and...
JTV®, the national jewelry retailer, broadcast network, and e-commerce platform, is excited to announce the highly anticipated addition of luxury sunglasses and watches to its portfolio of stunning jewelry, loose gemstones, and accessories. This...
Renoworks Software Inc. ("Renoworks" or the "Company), an industry leader in visualization and lead generation technology for the home renovation and new construction sector, announces its financial results for the year ended December 31, 2023. The...
TransAct Technologies Incorporated , a global leader in software-driven technology and printing solutions for high-growth markets, announced today that it will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024,...